IL6 and hyperthyroidism: Increased plasmatic concentrations of IL-6, IL-12, IL-18, fibrinogen, VCAM-1, and von Willebrand factor, reported in patients with hyperthyroidism and COVID-19 infection, may also contribute to the hypercoagulability state and increase the risk of thromboembolic events [89].